This content is machine translated Liver Cancer Artificial Intelligence in Precision Oncology—Opportunities and Challenges The 2025 ESMO Congress covered a wide range of translational and clinical topics, with the growing importance of artificial intelligence (AI) in diagnosis, prognosis, and treatment decisions standing out in...…
View Post 7 min This content is machine translated H. pylori infection: current study data Fewer gastric carcinomas and peptic ulcers after eradication Despite a worldwide decline in the prevalence of Helicobacter pylori (H. pylori), the infection is still widespread. It is estimated that around one in three people in Europe is colonized...…
View Post 6 min This content is machine translated Head and neck squamous cell carcinoma Precision immunotherapy and local treatment The role of immunotherapy in the treatment of locally advanced head and neck squamous cell carcinoma (LA-HNSCC) is currently being reassessed. At the SOHC Congress 2025 in Basel, Yungan Tao...…
View Post 4 min This content is machine translated From symptom to diagnosis Multilocular cystic renal cell carcinoma (MCRCC) MCRCC is a rare subtype of clear cell renal cell carcinoma of low malignant potential. This multilocular cystic neoplasm of the kidney presents with characteristic pathologic features and consists almost...…
View Post 3 min This content is machine translated Soft tissue sarcomas of the lower extremity Diagnostics, subtypes and treatment options Soft tissue sarcomas of the lower extremity are rare but clinically significant tumours that require precise diagnosis and a specialized treatment concept. Today, early detection, correct subtyping and modern interdisciplinary...…
View Post 3 min This content is machine translated Gastric carcinoma Ways of precision oncology New study data are fundamentally changing first-line treatment of metastatic gastric cancer. The ESMO on Air webinar on March 12, 2025 showed how biomarkers guide therapy selection and open up...…
View Post 8 min This content is machine translated Endometrial Cancer Immunological drivers and new therapeutic pathways Endometrial carcinoma is increasingly becoming the focus of modern tumor immunology as an immunologically characterized tumor disease. Molecular subtypes, microbiome interactions and a highly dynamic tumor immunological microenvironment are opening...…
View Post 8 min This content is machine translated When basal cell carcinomas prove difficult to treat Reaching the goal with innovative therapy strategies The further development of patient-oriented, function-preserving treatment strategies is an important concern of skin cancer research. For patients with advanced cutaneous basal cell carcinoma (BCC), there is a need for...…
View Post 4 min This content is machine translated Cholangiocarcinoma Modern molecular diagnostics and targeted therapy options Cholangiocarcinoma (CCA) is one of the most aggressive tumors of the hepatobiliary system and is often only diagnosed at an advanced stage. Advances in molecular diagnostics and targeted therapy are...…
View Post 4 min This content is machine translated HER2+ early breast cancer DESTINY-Breast11 – neoadjuvant T-DXd without anthracyclines The phase III DESTINY-Breast11 trial shows that neoadjuvant trastuzumab deruxtecan (T-DXd) could provide an anthracycline-free treatment option for HER2-positive early breast cancer. The results suggest an effective and better tolerated...…
View Post 5 min This content is machine translated Mantle cell lymphoma Recurrence after BTK inhibition – prognostic factors and treatment options Mantle cell lymphoma (MCL) is a rare B-cell non-Hodgkin’s lymphoma with a markedly heterogeneous course. The spectrum ranges from indolent, slowly progressive forms to highly aggressive variants. Diagnosis and treatment...…
